The impact of the HER2-low status on conditional survival in patients with breast cancer.

MLA

Ma, Teng, et al. “The Impact of the HER2-Low Status on Conditional Survival in Patients with Breast Cancer.” Therapeutic Advances in Medical Oncology, vol. 16, Jan. 2024, pp. 1–16. EBSCOhost, https://doi.org/10.1177/17588359231225039.

APA

Ma, T., Liu, C., Ma, T., Sun, X., Cui, J., Wang, L., Mao, Y., & Wang, H. (2024). The impact of the HER2-low status on conditional survival in patients with breast cancer. Therapeutic Advances in Medical Oncology, 16, 1–16. https://doi.org/10.1177/17588359231225039

Chicago

Ma, Teng, Changgen Liu, Tianyi Ma, Xinyi Sun, Jian Cui, Lulu Wang, Yan Mao, and Haibo Wang. 2024. “The Impact of the HER2-Low Status on Conditional Survival in Patients with Breast Cancer.” Therapeutic Advances in Medical Oncology 16 (January): 1–16. doi:10.1177/17588359231225039.